Bradbury Daniel's Form 4 filing
Castle Biosciences Inc (CSTL) · filed May 8, 2024
- Accession no.
- 0001447362-24-000064
- Filed
- May 8, 2024
- Trade date
- May 6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $574.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bradbury DanielCIK 0001236397 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 6, 2024 | Common Stock | SSaleDisposed | −7,393 | $24.64F2 | −$182,163.52 | 35,123 | Indirect | |
| May 6, 2024 | Common Stock | SSaleDisposed | −7,963 | $24.64F2 | −$196,208.32 | 9,981 | Indirect | |
| May 6, 2024 | Common Stock | SSaleDisposed | −7,967 | $24.64F2 | −$196,306.88 | 9,981 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $24.25 to $25.04, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.